Tag: Patient Risk

Kidney transplant performed on awake patient

Editor's Note In a first for Northwestern Medicine, surgeons performed a kidney transplant on an awake patient, CBS News reported June 24. John Nicholas, 28, of Chicago, experienced no pain during the May 24 procedure, in which he received an organ from a childhood friend. He was discharged the next…

Read More

By: Matt Danford
June 25, 2024
Share

Study: Preoperative weight loss offers little benefit for bariatric surgery patients

Editor's Note Research shows perioperative weight loss does not consistently improve outcomes or OR times in patients undergoing primary bariatric procedures, including laparoscopic sleeve gastrectomy (LSG) and laparoscopic Roux-en-Y gastric bypass (RYGB). The findings were published in the June issue of the Journal of the American College of Surgeons. Using…

Read More

By: Matt Danford
June 3, 2024
Share

Majority of American adults have CKM syndrome, at risk for heart disease

Editor's Note Nine out of 10 American adults have Cardiovascular, kidney, and metabolic syndrome (CKM)—interrelated factors that progress to heart disease—and almost 10% already have heart disease, according to a report published in JAMA by Brigham and Women’s Hospital and Harvard Medical School in Boston. HealthDay news reported on the…

Read More

By: Matt Danford
May 16, 2024
Share

FDA announces class 1 recall for disposable biopsy needle kit

Editor's Note Microscopic stainless steel debris on the insides of biopsy needles prompted the FDA to issue a class 1 recall—indicating risk of death or serious injury—for Elekta Instrument’s Disposable Biopsy Needle Kit, which is used with the Leksell Stereotactic System for brain tissue sampling during neurosurgery, the disposable biopsy…

Read More

By: Matt Danford
April 29, 2024
Share

Catheter sterility concerns prompt Class 1 FDA recall for surgery trays

Editor's Note The US Food and Drug Administration has designated DeRoyal Industries’ recall of GeoMed custom tracecarts a class 1, the most serious type of recall indicating a risk of serious injury or death. According to the April 24 FDA notice, the recall is due to sterility concerns with the…

Read More

By: Matt Danford
April 24, 2024
Share

AI model helps predict patient decline, drive collaborative care

JAMA (healthcare publication) Network logo

Editor's Note An AI prediction model that uses near-real-time data to generate a patient risk score shows the promise of AI for helping physicians and nurses coordinate on patient care, according to findings published March 25 in JAMA Internal Medicine. Performed by researchers at Stanford Medicine, the study examined an…

Read More

By: Brita Belli
April 24, 2024
Share

Unveiling ECRI’s 2024 Top 10 Patient Safety Concerns list

From integrating new technology to navigating shifts in care delivery and mitigating burnout, the most pressing challenges for healthcare organizations tend to be multifaceted problems that demand multifaceted solutions. For evidence of that, look no further than the Top 10 Patient Safety Concerns 2024 list from ECRI. For every risk…

Read More

By: Heather David, MSN, CRNP, AGACNP-BC, CSSYB
April 19, 2024
Share

FDA announces class 1 recalls for premixed embolic, infusion pump software

Editor's Note The US Food and Drug Administration has classified recalls of Boston Scientific’s Obsidio Conformable Embolic and Fresenius Kabi USA’s Ivenix Infusion System Large Volume Pump (LVP) software as class 1, the most serious category and an indicator of risk of serious injury or death. No injuries or deaths…

Read More

By: Matt Danford
April 18, 2024
Share

EPA rule to limit dangerous emissions from medical sterilization plants

USA Today logo

Editor's Note The Environmental Protection Agency (EPA) has finalized a rule to reduce chloroprene and ethylene oxide emissions that will impact over 200 chemical plants across the nation, including medical sterilization plants, according to an April 10 report from USA Today. Under the new rule, the EPA will cut more…

Read More

By: Brita Belli
April 11, 2024
Share

Study: GLP weight loss, diabetes therapies boost GI endoscopy pneumonia risk

Editor's Note Gastrointestinal endoscopy could increase the risk of aspirational pneumonia in patients using GLP-1 receptor agonists (RAs) to manage weight or treat diabetes, according to an April 1 report from MedPage today. Citing research published in the journal Gastroenterology by a team led by Kevin Sheng-Kai Ma, DDS, of…

Read More

By: Matt Danford
April 5, 2024
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat